Breast cancer is a complex, heterogeneous disease and one of the most common female cancers worldwide.
antioxidant and cytoprotective systems. 4 The antioxidant response is principally mediated by the transcription factor Nrf2, which induces the transcriptional activation of several genes involved in glutathione (GSH) synthesis, chemoresistance and cytoprotection. 5 In recent years, accumulating evidence implies the importance of Nrf2 deregulation in tumourigenesis. 5 Despite the recent progress in the characterization of Nrf2 transcription factors, biological functions of Nrf2 remain to be explored. Several types of cancer cells display a large amount of reactive oxygen species (ROS), due to an aberrant metabolism, mitochondrial dysfunction or activation of oncogenes. 6 Under physiological conditions, Nrf2 localizes in the cytoplasm where it is bound by Kelch-like ECH-associated protein 1 (Keap1).
Kelch-like ECH-associated protein 1 forms a complex with Cul3 and Rbx1, and this E3 ubiquitin ligase complex can bind and ubiquitinate Nrf2, resulting in Nrf2 proteasomal degradation. 7 The stabilized Nrf2 accumulates in nuclei, heterodimerizes with small Maf proteins and activates target genes for cytoprotection through the antioxidant response element (ARE)/electrophile response element (EpRE). 8 The function of Nrf2 in chemoresistance has been demonstrated in diverse types of cancers, including cisplatin resistant bladder cancers. 9 The migration and invasion of tumour cells are crucial in cancer metastasis. 10 Warburg effect is an important expression of tumour cell metabolic reprogramming. However, tumour metabolic reprogramming occurs in many metabolic pathways, including glycolysis, the pentose phosphate pathway (PPP) and the Krebs cycle process.
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The PPP is irreplaceable in the rapid proliferation of tumour cells regarding the provision of raw materials for macromolecular biosynthesis and maintenance of cellular redox status. 12 Recent studies have suggested that PPP is raised in many tumour cells, but maintenance of high hyperplastic in tumour cells through the PPP remains unanswered. Notch signalling pathway is a classical pathway. Recent studies show that Notch pathway was involved in cell proliferation, differentiation, migration and invasion. 13 It should be noted that Nrf2 is related to Notch pathway. 14 The synergy of Nrf2 and Notch pathway promotes survival rate of tumour cells, differentiation, invasion and metastasis in the condition of abnormal expression of Nrf2 and Notch pathway. 15 It is possible that Nrf2 can adjust the Notch pathway through affecting the PPP and leads to a change in breast cancer cell proliferation and migration, and need to explore its mechanism.
In this study, we demonstrate that Nrf2 leads to increased proliferation, migration, invasion in breast cancer cells. We found, for the first time, a novel function of Nrf2 in the Notch1 signalling pathway via PPP. Modulation of glucose-6-phosphate dehydrogenase (G6PD)/ Hypoxia inducing factor 1α (HIF-1α) expression by Nrf2 is therefore involved in the Notch1 pathway-mediated regulation proliferation, migration, invasion of breast cancer.
| MATERIAL S AND ME THODS

| Chemical reagents and antibodies
Polyclonal antibodies to Notch1, Notch2, Notch3, Notch4, Dll1, Dll3, Dll4, Jagged1, Jagged2, HIF-1α, N-cadherin, E-cadherin and Snail1 were purchased from Cell Signaling Technology (Beverly, MA).
Polyclonal antibodies to G6PD, transketolase (TKT), Nrf2, Keap1
and monoclonal antibody to β-actin were purchased from Abcam (Cambridge, UK). The dual-luciferase reporter assay kit was obtained from Promega (Madison, WI).
| Cell culture
Human breast cancer cells (MCF-7, MDA-MB-231) were grown in DMEM containing 10% foetal bovine serum (FBS) and 1% penicillinstreptomycin solution in 5% CO 2 at 37°C. Normal human mammary epithelial cells, MCF-10A cells, were maintained in DMEM/F12 (Invitrogen, Carlsbad, CA) supplemented with 5% horse serum (Invitrogen, Carlsbad, CA, USA), 20 ng/mL epidermal growth factor (Sigma-Aldrich, St. Louis, MO), 0.5 μg/mL hydrocortisone (Sigma-Aldrich), 10 μg/mL insulin (Sigma-Aldrich), 100 ng/mL cholera toxin (Sigma-Aldrich) and 100 U/mL penicillin/streptomycin. HEK-293T cells were grown in DMEM supplemented with 10% FBS and 100 U/mL penicillin/streptomycin.
| Plasmid construction and virus packaging
The The media containing progeny virus released from HEK-293T cells were collected and used to transduce specific cells. 16 The cloning strategy sequences were as following: GBD- NRF2-F: 5′-TGA   CCT CCA TAG AAG ATT CTA GAA TGA TGG ACT TGG AGC TGC   CGC-3′; GBD-NRF2-R: 5′-GCG ATC GCA GAT CCT TCG CGG CCG   CCT AGT TTT TCT TAA CAT CTG GCT TCT TAC TTT TGG GAA   CAA GG-3′; GBD-KEAP1-F: 5′-TGA CCT CCA TAG AAG ATT CTA   GAA TGC AGC CAG ATC CCA GGC C-3′; GBD-KEAP1-R: 5′-GCG   ATC GCA GAT CCT TCG CGG CCG CTC AAC AGG TAC AGT TCT   GC TGG TCA AT C TG-3′; ShNRF2-F: 5′-GAT CCG TAA GAA GCC   AGA TGT TAA CTC GAG TTA ACA TCT GGC TTC TTA CGC TTT   TTG G-3′; ShNRF2-R: 5′-AAT TCC AAA AAG CGT AAG AAG   CCA GAT GTT AAC TCG AGT TAA CAT CTG GCT TCT TAC G- 
| Western blotting
| Wound healing assay
Cells were cultured in six-well plates and incubated in culture medium at 37°C in a 5% CO 2 incubator. A wound area was made with a 200 μL pipette tip following formation of a confluent monolayer.
Cells were then incubated in the same condition for 24 hours. Images were captured at 0 and 24 hours. All experiments were performed in triplicates. 16 
| Transwell cell invasion assays
Transwell cell invasion assays were performed as previously described. 10 In brief, an appropriate number of cells was seeded in the upper insert chamber with serum-free medium. DMEM (500 μL) containing 10% FBS was plated at the bottom chamber. After 24 hours incubation, cells were rinsed and stained with crystal violet solution (Sigma-Aldrich). All the results of transwell assay have been quantified by counting the invasive cell number.
| Luciferase assay
The System (Promega) and a BioTek Luminometer. Firefly luciferase activity was normalized to activity of Renilla Luciferase. For each experiment, the luciferase assay was performed three times.
| Statistical analysis
ANOVA was used for three-group comparisons; consequence was displayed as mean ± standard error of mean (mean ± SEM). A P-value less than 0.05 was considered statistically significant.
| RE SULTS
| Nrf2 overexpression and Keap1 knockdown promote proliferation and migration of breast cancer cells
To 
| Nrf2 regulated Notch1 signalling in breast cancer cells
The main functions of Notch pathway are regulating cells proliferation and migration. 20 In order to explore the influence of Nrf2 on Notch pathway in breast cancer cells, the expression of ligand It is suggested that Nrf2 is positively correlated with Notch1 in breast cancer.
| Nrf2 regulated Notch1 signalling via G6PD/ HIF-1α in breast cancer cells
In order to determine whether Nrf2 directly activated Notch1 signalling pathway, Notch1-promoter luciferase activity was assayed in MCF-7 and MDA-MB-231 cells. The results show that Notch1-promoter luciferase activity was not affected by Nrf2 overexpression or Nrf2 knockdown in MCF-7 and MDA-MB-231 cells ( Figure 5A ).
We assume that Nrf2 regulated Notch1 through PPP. The G6PD
and TKT knockdown plasmid PLVX-shG6PD and PLVX-shTKT and 
| Nrf2 can affect breast cancer cell proliferation and migration by influencing the expression of Notch1
One of the main functions of the Notch pathway involves regulating breast cancer cell proliferation and migration. 21 We assumed that the effect of Nrf2 on breast cancer cell proliferation and migra- by DAPT (Figure 7D-F) . Therefore, we suggest that Nrf2 controls 
| D ISCUSS I ON
Metabolic reprogramming by transcription factor Nrf2 could contribute to the development of breast cancer. 11 However, the mechanisms that drive breast cancer progression need further research. NF-E2-related factor 2 is important in protection of oxidative stress. However, some studies have shown that the survival and development of cancer cells were promoted through excessive expression of Nrf2 and its target genes. 22 Recent data suggest that the there are different degrees of Keap1 mutations in patients with lung cancer. 23 Activation of Nrf2 can promote cell tumourigenicity, and knockdown of Nrf2 can inhibit tumour growth, metastasis and invasion. 24 The target genes of Nrf2 are vital in tumour metastasis. The main function of heme oxygenase 1 (HO-1), the main target gene of Nrf2, is to participate in maintaining cells redox equilibrium.
It is reported that the survival rate of lung cancer patients with high level of HO-1 is lower than patients with low expression of HO-1. higher expression. 26 In this study, we observed that high levels of Nrf2 expression significantly correlated with higher proliferation and migration of breast cancers cells, all of which precludes shorter overall survival and a higher recurrence rate in breast cancer patients. These observations suggest that Nrf2 promotes breast cancer metastasis and may serve as a biomarker for poor prognosis.
In addition to its role in regulation of oxidative stress, Nrf2 also involves in the anabolic metabolism. NF-E2-related factor 2 directly activates six genes involved in PPP and NADPH production pathway, including G6PD, PGD, TKT, TALDO1 and malic enzyme 1 (ME1), through binding of this transcription factor to AREs of these gene promoters.
11
The metabolic reprogramming provides energy and metabolites to facilitate rapid growth and proliferation of cancer cells. The PPP is important in promoting cancer proliferation, differentiation and survival. 27 Overexpression of G6PD is a prognostic factor in multiple cancers and is associated with tumour progression, metastasis or recurrent disease. 28 The oxidative PPP converts G6P, a glycolytic intermediate, into
ribulose-5-phosphate and generates NADPH, which is used for GSH production, detoxification and biosynthesis of lipids. Pentose phosphate pathway is up-regulated in many types of tumours. The activities of G6PD and TKT, key PPP enzymes, were increased in cancer cells. 29 In this work, we found that the two key PPP enzymes, G6PD and TKT, 
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